Virtus Biotech Clinical TriaBBCETF
13F holders, Q2 2025 (June 30)11holders +2
4new positions
2sold out
$19.32avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings, up 2 from Q1 2025. 4 opened new positions and 2 sold out. The largest holders were Militia Capital Partners, LP ($834K), LPL Financial LLC ($241K) and UBS Group AG ($217K).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q2 2025)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $1.3M |
| Exits | 2 | $546K |
All 13F filers, Q1 2025 → Q2 2025: 66,418 shares bought and 31,333 shares sold, net +35,085 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Militia Capital Partners, LP | 0.39% | New | 43,193 | $834K |
| LPL Financial LLC | 0.00% | Add +4.9% | 12,496 | $241K |
| UBS Group AG | 0.00% | New | 11,216 | $217K |
| Susquehanna International Group, LLP | 0.00% | New | 11,113 | $215K |
| Morgan Stanley | 0.00% | Add +0.1% | 8,455 | $163K |
| US Bancorp \de | 0.00% | No change | 1,000 | $19K |
| Dynamic Wealth Strategies, LLC | 0.01% | No change | 802 | $15K |
| Osaic Holdings, Inc. | 0.00% | New | 303 | $6K |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -62.6% | 110 | $2K |
| Allworth Financial LP | 0.00% | No change | 10 | $194 |
| NewEdge Advisors, LLC | 0.00% | No change | 5 | $97 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.